• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用相对活性因子预测细胞色素P450s对人肝微粒体中药物代谢的贡献取决于探针。

Predicted contributions of cytochrome P450s to drug metabolism in human liver microsomes using relative activity factor were dependent on probes.

作者信息

Wang Shuting, Tang Xiange, Yang Tingting, Xu Jiong, Zhang Jiaxin, Liu Xiaodong, Liu Li

机构信息

a Center of Drug Metabolism and Pharmacokinetics, School of Pharmacy , China Pharmaceutical University , Nanjing , China.

出版信息

Xenobiotica. 2019 Feb;49(2):161-168. doi: 10.1080/00498254.2018.1433902. Epub 2018 Feb 8.

DOI:10.1080/00498254.2018.1433902
PMID:29375004
Abstract

Contributions of cytochrome P450 (CYP450) isoforms to drug metabolism are often predicted using relative activity factor (RAF) method, assuming RAF values were independent of probe. We aimed to report probe-dependent characteristic of RAF values using CYP3A4 or CYP2C9 probes. Metabolism of four CYP3A4 probes (testosterone, midazolam, verapamil and atorvastatin) and three CYP2C9 probes (tolbutamide, diclofenac and S-warfarin) in human liver microsomes (HLM) and cDNA-expressed recombinant CYP450 (Rec-CYP450) systems were characterized and RAF value was estimated as ratio of probe intrinsic clearance in HLM to that in Rec-CYP450. CYP450i contributions to metabolic reaction of a probe were predicted using other probes and compared with data from specific inhibitions. Contributions of CYP3A4 and CYP2C9 to metabolism of deoxypodophyllotoxin and nateglinide were also predicted. RAF values were dependent on probes, leading to probe-dependently predicted contributions. Predicted contributions of CYP3A4 to formations of 6β-hydroxytestosterone, 1'-hydroxymidazolam, norverapamil, ortho-hydroxyatorvastatin and para-hydroxyatorvastatin using other probes were 47.46-219.46%, 21.62-98.87%, 186.49-462.44%, 21.87-101.15% and 53.62-247.97%, respectively. Predicted contributions of CYP3A4 and CYP2C9 to nateglinide metabolism were 8.18-37.84% and 36.08-94.04%, separately. In conclusion, CYP450i contribution to drug metabolism in HLM estimated using RAF approach were probe-dependent. Therefore, contribution of each isoform must be confirmed by multiple probes.

摘要

细胞色素P450(CYP450)同工型对药物代谢的贡献通常使用相对活性因子(RAF)方法来预测,假定RAF值与探针无关。我们旨在报告使用CYP3A4或CYP2C9探针时RAF值的探针依赖性特征。对四种CYP3A4探针(睾酮、咪达唑仑、维拉帕米和阿托伐他汀)以及三种CYP2C9探针(甲苯磺丁脲、双氯芬酸和S-华法林)在人肝微粒体(HLM)和cDNA表达的重组CYP450(Rec-CYP450)系统中的代谢进行了表征,并将RAF值估计为HLM中探针固有清除率与Rec-CYP450中探针固有清除率的比值。使用其他探针预测CYP450同工型对一种探针代谢反应的贡献,并与特异性抑制数据进行比较。还预测了CYP3A4和CYP2C9对脱氧鬼臼毒素和那格列奈代谢的贡献。RAF值取决于探针,导致对贡献的预测具有探针依赖性。使用其他探针预测CYP3A4对6β-羟基睾酮、1'-羟基咪达唑仑、去甲维拉帕米、邻羟基阿托伐他汀和对羟基阿托伐他汀形成的贡献分别为47.46 - 219.46%、21.62 - 98.87%、186.49 - 462.44%、21.87 - 101.15%和53.62 - 247.97%。预测CYP3A4和CYP2C9对那格列奈代谢的贡献分别为8.18 - 37.84%和36.08 - 94.04%。总之,使用RAF方法估计的HLM中CYP450同工型对药物代谢的贡献具有探针依赖性。因此,每种同工型的贡献必须通过多种探针来确认。

相似文献

1
Predicted contributions of cytochrome P450s to drug metabolism in human liver microsomes using relative activity factor were dependent on probes.使用相对活性因子预测细胞色素P450s对人肝微粒体中药物代谢的贡献取决于探针。
Xenobiotica. 2019 Feb;49(2):161-168. doi: 10.1080/00498254.2018.1433902. Epub 2018 Feb 8.
2
Impact of Probe Substrate Selection on Cytochrome P450 Reaction Phenotyping Using the Relative Activity Factor.使用相对活性因子时探针底物选择对细胞色素P450反应表型分析的影响。
Drug Metab Dispos. 2017 Feb;45(2):183-189. doi: 10.1124/dmd.116.073510. Epub 2016 Dec 1.
3
Interspecies differences in metabolism of deoxypodophyllotoxin in hepatic microsomes from human, monkey, rat, mouse and dog.人、猴、大鼠、小鼠和犬肝脏微粒体中脱氧鬼臼毒素代谢的种间差异。
Drug Metab Pharmacokinet. 2016 Aug;31(4):314-22. doi: 10.1016/j.dmpk.2016.05.002. Epub 2016 May 15.
4
Are there differences in the catalytic activity per unit enzyme of recombinantly expressed and human liver microsomal cytochrome P450 2C9? A systematic investigation into inter-system extrapolation factors.重组表达和人肝微粒体细胞色素 P450 2C9 的单位酶催化活性是否存在差异?系统研究跨系统外推因子。
Biopharm Drug Dispos. 2011 Sep;32(6):303-18. doi: 10.1002/bdd.760. Epub 2011 Jul 4.
5
In vitro metabolism of midazolam, triazolam, nifedipine, and testosterone by human liver microsomes and recombinant cytochromes p450: role of cyp3a4 and cyp3a5.咪达唑仑、三唑仑、硝苯地平及睾酮在人肝微粒体和重组细胞色素P450中的体外代谢:CYP3A4和CYP3A5的作用
Drug Metab Dispos. 2003 Jul;31(7):938-44. doi: 10.1124/dmd.31.7.938.
6
Relative contributions of the major human CYP450 to the metabolism of icotinib and its implication in prediction of drug-drug interaction between icotinib and CYP3A4 inhibitors/inducers using physiologically based pharmacokinetic modeling.主要人类细胞色素P450对埃克替尼代谢的相对贡献及其在使用基于生理的药代动力学模型预测埃克替尼与CYP3A4抑制剂/诱导剂之间药物相互作用中的意义。
Expert Opin Drug Metab Toxicol. 2015 Jun;11(6):857-68. doi: 10.1517/17425255.2015.1034688. Epub 2015 Apr 8.
7
Relative contributions of the five major human cytochromes P450, 1A2, 2C9, 2C19, 2D6, and 3A4, to the hepatic metabolism of the proteasome inhibitor bortezomib.五种主要的人类细胞色素P450,即1A2、2C9、2C19、2D6和3A4,对蛋白酶体抑制剂硼替佐米肝脏代谢的相对贡献。
Drug Metab Dispos. 2005 Nov;33(11):1723-8. doi: 10.1124/dmd.105.005710. Epub 2005 Aug 15.
8
The Impact of the Hepatocyte-to-Plasma pH Gradient on the Prediction of Hepatic Clearance and Drug-Drug Interactions for CYP2C9 and CYP3A4 Substrates.肝细胞与血浆pH梯度对CYP2C9和CYP3A4底物肝清除率预测及药物相互作用的影响
Drug Metab Dispos. 2017 Sep;45(9):1008-1018. doi: 10.1124/dmd.117.076331. Epub 2017 Jul 5.
9
Comparison of cytochrome P450 inhibition assays for drug discovery using human liver microsomes with LC-MS, rhCYP450 isozymes with fluorescence, and double cocktail with LC-MS.使用液相色谱-质谱联用技术检测人肝微粒体、荧光检测重组人细胞色素P450同工酶以及液相色谱-质谱联用技术检测双鸡尾酒法进行药物发现的细胞色素P450抑制试验的比较。
Int J Pharm. 2007 Apr 20;335(1-2):1-11. doi: 10.1016/j.ijpharm.2006.10.039. Epub 2006 Nov 10.
10
Quantitative prediction of macrolide drug-drug interaction potential from in vitro studies using testosterone as the human cytochrome P4503A substrate.以睾酮作为人细胞色素P4503A底物,通过体外研究对大环内酯类药物相互作用潜力进行定量预测。
Eur J Clin Pharmacol. 2006 Mar;62(3):203-8. doi: 10.1007/s00228-005-0091-x. Epub 2006 Jan 17.

引用本文的文献

1
Enhancing Atorvastatin In Vivo Oral Bioavailability in the Presence of Inflammatory Bowel Disease and Irritable Bowel Syndrome Using Supercritical Fluid Technology Guided by wbPBPK Modeling in Rat and Human.利用超临界流体技术并结合大鼠和人体的 wbPBPK 模型指导,增强炎症性肠病和肠易激综合征大鼠和人体中阿托伐他汀的口服生物利用度。
AAPS PharmSciTech. 2022 May 18;23(5):148. doi: 10.1208/s12249-022-02302-z.
2
Towards the Elucidation of the Pharmacokinetics of Voriconazole: A Quantitative Characterization of Its Metabolism.迈向伏立康唑药代动力学的阐明:其代谢的定量表征
Pharmaceutics. 2022 Feb 22;14(3):477. doi: 10.3390/pharmaceutics14030477.